Healthtech funding in 2022
European Healthtech startup funding raised during 2022.
In 2022, 616 European Healthtech companies closed 656 funding rounds and raised €7.6B in equity funding (excluding debt and grants). Debt rounds added €1.1B. UK led by capital raised, and Bpifrance was the most active investor. Data as of 19 Nov 2026.
Equity funding
€7.6B
excl. debt & grants · +€1.1B debt
Funding rounds
656
Companies
616
Top country
UK
Healthtech: last three years
change vs the year beforeRank among sectors
#4
8.0% of sector funding
Debt financing
€1.1B
12.9% of total
Top-10 round share
20.5%
of disclosed capital
Rounds ≥ €100M
11
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2022 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €1.0B | 65 |
| Feb | €790M | 60 |
| Mar | €916M | 46 |
| Apr | €475M | 44 |
| May | €529M | 47 |
| Jun | €927M | 67 |
| Jul | €927M | 52 |
| Aug | €701M | 42 |
| Sep | €523M | 51 |
| Oct | €726M | 66 |
| Nov | €729M | 62 |
| Dec | €526M | 54 |
Top countries
by € raisedHealthtech — top countries by capital, 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, 2022 | |
|---|---|
| UK | €2.3B |
| France | €1.5B |
| Germany | €1.2B |
| Switzerland | €1.1B |
| Netherlands | €501M |
| Sweden | €452M |
| Belgium | €345M |
| Spain | €344M |
Stage mix
by € raisedHealthtech — stage mix, 2022 — interactive chart.
Data table
| Healthtech — stage mix, 2022 | |
|---|---|
| Other | €3.2B |
| Series B | €1.7B |
| Series A | €1.6B |
| Debt | €1.1B |
| Seed | €419M |
| Series C | €386M |
| Series D+ | €226M |
| Grant | €62M |
| Pre-Seed | €28M |
| Growth/Late | €16M |
| Crowdfunding | €5.5M |
| Early VC | €2.5M |
Exits & M&A
66 Acquisition · 2 IPO68 exits · €13B disclosed.
| Pharma Intelligence | Acquisition | Feb 2022 | €2.3B |
| Immucor | Acquisition | Nov 2022 | €2.0B |
| Norgine | Acquisition | Jun 2022 | €1.8B |
| Zogenix | Acquisition | Jan 2022 | €1.7B |
| TeneoTwo | Acquisition | Jul 2022 | €1.2B |
| SPT Labtech | Acquisition | Jun 2022 | €757M |
Largest equity rounds
by disclosed amount, 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Cera | Other | Aug 2022 | €157M |
| Kry | Other | Jul 2022 | €157M |
| Vectivbio | Other | Oct 2022 | €127M |
| Novaremed | Other | Jul 2022 | €127M |
| Patient21 | Other | Jan 2022 | €126M |
| Leyden Labs | Series B | Jan 2022 | €124M |
| TauRx Pharmaceuticals | Other | Nov 2022 | €115M |
| Kerecis | Series D+ | Jul 2022 | €99M |
| Imcheck Therapeutics | Other | Jun 2022 | €96M |
| MindMaze | Other | Feb 2022 | €92M |
Largest debt rounds
debt financing, 2022; not in the equity totalTop investors
most active in 2022, by deal count- Bpifrance16 deals
- High-Tech Gründerfonds (HTGF)12 deals
- Calm Storm Ventures9 deals
- EIC Accelerator9 deals
- Speedinvest9 deals
- Venture Kick9 deals
- Verve Ventures9 deals
- Capital Cell8 deals
- Innovate UK8 deals
- Octopus Ventures8 deals
Source: Tech.eu Funding Explorer · data as of 19 Nov 2026 · licence CC BY 4.0 · Methodology